
4.73 Delayed Data As of Mar 05 | ![]() Today’s Change | 3.74 Today|||52-Week Range 33.94 | -32.91% Year-to-Date |
SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $238.2M |
Tricida, Inc. 7000 Shoreline Court South San Francisco California 94080 |
Gerrit Klaerner | President, Chief Executive Officer & Director |
Geoffrey M. Parker | Executive VP, Chief Operating & Financial Officer |
Wilhelm Stahl | Chief Technology Officer & Senior Vice President |
Dawn Parsell | Executive Vice President-Clinical Development |
Elizabeth A. Faust | Executive Vice President-Medical Affairs |